Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-20-002573
Filing Date
2020-04-24
Accepted
2020-04-24 16:42:52
Documents
57
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2241303z20-f.htm 20-F 1700785
2 EX-2.3 a2241303zex-2_3.htm EX-2.3 34096
3 EX-2.6 a2241303zex-2_6.htm EX-2.6 163290
4 EX-8.1 a2241303zex-8_1.htm EX-8.1 7606
5 EX-12.1 a2241303zex-12_1.htm EX-12.1 11051
6 EX-12.2 a2241303zex-12_2.htm EX-12.2 11061
7 EX-13.1 a2241303zex-13_1.htm EX-13.1 6292
8 EX-15.1 a2241303zex-15_1.htm EX-15.1 2337
15 G183763MAI001.GIF g183763mai001.gif GRAPHIC 3088
  Complete submission text file 0001047469-20-002573.txt   7759142

Data Files

Seq Description Document Type Size
9 EX-101.INS fwp-20191231.xml EX-101.INS 1851151
10 EX-101.SCH fwp-20191231.xsd EX-101.SCH 51112
11 EX-101.CAL fwp-20191231_cal.xml EX-101.CAL 51615
12 EX-101.DEF fwp-20191231_def.xml EX-101.DEF 165874
13 EX-101.LAB fwp-20191231_lab.xml EX-101.LAB 421147
14 EX-101.PRE fwp-20191231_pre.xml EX-101.PRE 305813
Mailing Address OSTERGADE 24A, 1 COPENHAGEN G7 1100
Business Address OSTERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36686 | Film No.: 20815644
SIC: 2834 Pharmaceutical Preparations